To evaluate the T cell response induced by anti-DEC-205:16E5 vaccination, the mice were inoculated with BMK-16/myc tumor cells and treated with the anti-DEC-205:16E5 conjugate, free 16E5 or PBS plus adjuvant, using the protocol previously described. This evidence concerns the gene MYC and neoplasm.